Sciensus Showcases New Data at ISPOR and ASCO 2026, Strengthening Leadership in Rare Disease and Oncology Care
Evidence-driven insights advance treatment access and care delivery in complex conditions LONDON, UNITED KINGDOM, April 23, 2026 /EINPresswire.com/ -- Sciensus today announced five accepted abstracts across ISPOR 2026 (May 17–20, Philadelphia) …